Transthoracic echocardiography for precardioversion screening during atrial flutter/fibrillation in young patients by Horenstein, M. Silvana et al.
Transthoracic Echocardiography for Precardioversion Screening during Atrial
Flutter/Fibrillation in Young Patients
M. SILVANA HORENSTEIN, M.D., PETER P. KARPAWICH, M.D., MICHAEL L. EPSTEIN, M.D., TAJINDER P. SINGH, M.D.
Division of Cardiology, Department of Pediatrics, Children’s Hospital of Michigan, Wayne State University School of Medicine,
Detroit, Michigan, USA
Summary
Background: Transthoracic echocardiography (TTE) is re-
liable for detection of thrombi in the left ventricle and right
atrium, but not in the left atrial appendage. Therefore, trans-
esophageal echocardiography (TEE) is routinely performed in
adults prior to electric cardioversion for atrial flutter/fibrilla-
tion (AFF). Whether young survivors of congenital heart dis-
ease repair with AFF need routine TEE prior to electric car-
dioversion is unknown.
Hypothesis: Electric cardioversion for AFF is safe in sur-
vivors of congenital heart disease repair/palliation if an intra-
cardiac thrombus is not suspected on TTE imaging.
Methods: This study reports the outcome of patients in a pe-
diatric tertiary care cardiac unit where electric cardioversion
was performed if no intracardiac thrombus was suspected on
TTE. We performed a retrospective chart review of all patients
treated with electric cardioversion for AFF at Children’s Hos-
pital of Michigan during 1997–2002
Results: Of 35 patients who presented with 110 episodes of
AFF requiring electric cardioversion during the study dura-
tion, 32 (age 3 months–49 years, median age 20.5 years, 104
AFF episodes) had previously undergone palliative surgery or
repair of their congenital heart disease. Of these 32 patients, 18
were survivors of a Fontan palliation (for a single-ventricle
variant) and the remaining 14 were survivors of other defects
and repairs (septal defects, valve replacements, and tetralogy
of Fallot). During 81% of the episodes, patients were receiving
aspirin, warfarin, or heparin for anticoagulation at presenta-
tion. Transthoracic echocardiography was performed in 74
AFF episodes; of these, 10 TTE studies were suspicious for
atrial thrombi. Transesophageal echocardiography confirmed
the presence of a thrombus in 3 of these 10 patients. These pa-
tients received warfarin for 2 weeks and then underwent elec-
tric cardioversion. No thromboembolic events occurred im-
mediately after or on follow-up in any patient.
Conclusions: These findings suggest that TTE may be an
effective imaging tool for precardioversion screening in young
patients with AFF.
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Introduction
Atrial flutter and atrial fibrillation (AFF) are supraventricu-
lar tachyarrhythmias that may be complicated by the develop-
ment of atrial thrombi. In adults, the incidence of AFF is <1%
in subjects with normal cardiac anatomy who are aged < 60
years. The incidence rises to 16% in men and 13% in women
aged > 80 years.1, 2 A similar high incidence of AFF has been
reported in pediatric survivors of palliative surgery of complex
congenital heart disease (CHD).3 Direct damage to the sinus
node or to its blood supply during surgery, conduction block at
the suture line, and atrial dilatation all provide an electrophys-
iologic substrate that promotes spontaneous AFF.4–6
Atrial tachyarrhythmias are often poorly tolerated in sur-
vivors of complex CHD due to their coexisting hemodynamic
alterations and are considered an important cause of morbid-
ity and mortality.7 Because of the potential for rapid develop-
ment of ventricular dysfunction and hemodynamic compro-
mise, cardioversion soon after diagnosis is the preferred treat-
ment for these patients if there are no intracardiac thrombi.8
This is in contrast to the therapeutic strategy of 3–4 weeks of
anticoagulation prior to electric cardioversion in older patients
with normal cardiac anatomy and normal ventricular func-
tion, who tend to tolerate AFF well if the ventricular rate is
controlled.5
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Transthoracic echocardiography (TTE) is considered re-
liable for detection of thrombi in the left ventricle and right
atrium; however, because TTE lacks the sensitivity to detect
thrombi in the left atrial appendage, transesophageal echocar-
diography (TEE) is routinely performed in adults prior to elec-
tric cardioversion for AFF.9–12 Survivors of CHD repair with
AFF may be at higher risk of developing right atrial (versus
left atrial) thrombi due to local stasis. Furthermore, the smaller
chest dimensions of children and young adults often allow ac-
ceptable spatial resolution with TTE. The need for routine
TEE in these subjects prior to electric cardioversion for AFF is
unknown. We report the clinical outcome in a cohort of young
patients at a pediatric tertiary care cardiac unit, in whom elec-
tric cardioversion was performed without TEE if a screening
TTE demonstrated no intracardiac thrombus.
Methods
After obtaining approval from the Institutional Human In-
vestigation Committee, a retrospective chart review for all pa-
tients treated with electric cardioversion for AFF at our institu-
tion during 1997–2002 was performed. Charts were reviewed
for patient clinical characteristics, results of imaging studies
(TTE and TEE) performed during AFF and in sinus rhythm,
effectiveness of electric cardioversion in restoring sinus/orga-
nized atrial rhythm, and patient follow-up after cardioversion.
Results
Patient Characteristics
A total of 35 patients presented with 110 episodes of AFF
requiring electric cardioversion during the study duration. Of
these, 32 (age 3 months–49 years, median age 20.5 years, 104
AFF episodes) had previously undergone surgical palliation or
repair for CHD. A single-ventricle variant (following pallia-
tive Fontan surgery) was the most common underlying diag-
nosis (18 patients, 73 AFF episodes). The remaining 14 pa-
tients had undergone surgery for other defects (Table I). The
mean age at Fontan palliation was 3.8 years (median 1.6 years)
and at first cardioversion was 17.3 years. Of the 18 patients, 17
underwent classic (atriopulmonary connection) and 1 patient
underwent modified (intracardiac total cavopulmonary con-
nection) Fontan procedure. During the study duration, 5 of the
17 patients with atriopulmonary connection underwent “revi-
sion” surgery to intracardiac total cavopulmonary connection
due to recurrent AFF.
During 81% of AFF episodes, patients were receiving anti-
coagulation or antiplatelet aggregation therapy at presentation
prior to the onset of this arrhythmia (aspirin in 43 AFF, war-
farin in 26 AFF, heparin in 4 AFF; Table I).
Imaging Studies
Transthoracic echocardiography was performed during 74
AFF episodes. No imaging studies were performed prior to
cardioversion in 30 episodes because the patient was either
known to be on adequate anticoagulation or presented within
hours of a clearly defined onset of AFF.
In most patients who underwent TTE, the right atrium and
apical parts of the ventricles were well visualized. Because
quantification of ventricular function by echocardiography is
technically difficult in patients with single-ventricle anatomy
or with a systemic right ventricle, it is based on subjective eval-
uation. Compared with previous imaging studies performed
during sinus rhythm, 35% of TTEs during AFF showed nor-
mal cardiac function, 39% showed mildly impaired function,
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TABLE I Clinical characteritics and echocardiography procedures in patient population
Caridac No. of N (AFF Age N N Thrombus
disease Intervention patients episodes) Anticoagulation (years)b (TTE) (TEE) location
ASD a Percutaneous device closure 1 2 A = 2; W = 0; H = 0 45 2 0
ASD Surgical ASD closure 2 2 A = 1; W = 0; H = 0 26 2 0
AVC Surgical AVC closure 1 1 A = 0; W = 0; H = 0 0.3 1 0
TOF Transannular patch 1 2 A = 0; W = 2; H = 1 26 2 0
TV Endo TV replacement 1 4 A = 2; W = 0; H = 0 18 4 1(T) RA wall
Ebstein TV replacement 1 1 A = 1; W = 0; H = 0 18 1 1
DORV Bi-ventricular repair 2 10 A = 10;W = 0; H = 0 28 9 0
D-TGA Mustard palliation 4 7 A = 2; W = 1; H = 1 20 6 0
L-TGA Rastelli operation 1 2 A = 2; W = 0; H = 0 25 2 0
Single ventricule Fontan palliation 18 73 A = 28; W = 23; H = 2 17 45 8 (T), (T) RA roof
Total 32 104 A = 48; W = 26; H = 4 22 74 10
a Percutaneous closure.
b Mean age at first cardioversion.
Abbreviations: ASD = atrial septal defect, AVC = atrioventricular canal, TOF = tetralogy of Fallot, DORV = double outlet right ventricle, 
D-TGA = (dextro) transposition of the great arteries, L-TGA = (levo) congenitally corrected transposition of the great arteries, TV = tricuspid
valve, Endo = endocarditis, AFF = atrial flutter/fibrillation episodes, TTE = transthoracic echocardiogram, TEE = tranesophageal echocardio-
gram, RA = right atrium, (T) = thrombus confirmed by TEE in 1 of AFF episodes, A = aspirin, W = warfarin, H = heparin.
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and 26% showed severely impaired function. Ventricular
function was normal during sinus rhythm in 70% (prior to on-
set of AFF or after conversion to sinus rhythm).
Ten TTE studies were considered suspicious for presence
of atrial thrombi. Transesophageal echocardiography was per-
formed in all 10 patients and confirmed the presence of an atri-
al thrombus in 3, all in the right atrium. Two of the three pa-
tients had undergone atriopulmonary Fontan palliation for
single ventricle. At the time of AFF, there was mildly impaired
ventricular function in one and severely impaired ventricular
function in another patient. One patient had previous tricuspid
valve replacement with an allograft with normal ventricular
function at the time of AFF. All three patients received aspirin
prior to onset of AFF and were treated with warfarin for 2
weeks after the diagnosis of atrial thrombus was confirmed by
TEE; they subsequently underwent cardioversion. In seven
patients in whom TEE did not demonstrate an intracardiac
thrombus, TTE images were either of poor quality due to tech-
nical difficulties or interpreted slow blood flow in a dilated
large right atrium (sometimes described as “smoke”) to be
suspicious for thrombus.
Cardioversion Treatment
Electric cardioversion was effective in restoring normal
rhythm in all AFF episodes. No recognized thromboembolic
events occurred immediately after cardioversion or during
follow-up.
Discussion
The majority of older adults presenting with spontaneous
AFF, usually atrial fibrillation, have normal cardiac anatomy
and tolerate this chaotic atrial rhythm well if the ventricular
rate is controlled with interventions that slow atrioventricular
conduction. Because of the risk of thromboembolism and
stroke following cardioversion, the current management prac-
tice in these patients with AFF consists of anticoagulation
with warfarin for 3–4 weeks prior to cardioversion.5 This
paradigm has been challenged recently by a study that demon-
strated that in the absence of atrial thrombi on TEE, cardiover-
sion may be performed immediately after the diagnosis of
AFF without increasing the incidence of thrombolembolic
events/strokes, thus avoiding the need for prolonged anticoag-
ulation prior to cardioversion.12
The results of our study suggest, however, that in a young
population with CHD presenting with AFF, even routine TEE
may not be necessary prior to electrical cardioversion. With
TTE as the “screening” imaging modality and TEE limited to
patients in whom TTE was suspicious of an intracardiac
thrombus, none of the patients developed any clinically de-
tectable systemic or pulmonary embolism following car-
dioversion, either acutely or on follow-up. These results have
several potential explanations. First, because younger patients
exhibit better spatial resolution due to a leaner habitus, TTE
may have a higher sensitivity in detecting intracardiac throm-
bi in this population. Second, the majority of these patients
were postoperative Fontan patients who are much more like-
ly to develop stasis in their right than in the left atrium, and
TTE may be adequately sensitive for detecting right atrial
thrombus. Finally, younger subjects may be more likely to
maintain the function of their left atrial appendage during
AFF and may thus have a lower propensity for developing a
thrombus in that location.13, 14
Due to right atrial hypertension and consequent distension,
AFF is particularly common in those patients who underwent
classic Fontan surgery (atriopulmonary connection).4, 7 Anti-
platelet aggregation prophylaxis with aspirin is a common
practice in these patients and explains why the majority of pa-
tients underwent this therapy when AFF was first diagnosed.
This surgery is no longer preferred in patients with single ven-
tricles and has been replaced by modified Fontan surgery (to-
tal cavopulmonary connection) with the goal of decreasing the
incidence of AFF in these patients. It should be noted that all
three patients who developed an atrial thrombus during AFF
(confirmed by TEE) received aspirin therapy. This finding
suggests that aspirin is not very effective in preventing atrial
thrombus formation in these high-risk patients.
Study Limitations
This study is limited by its retrospective design and a small
patient population. Furthermore, since TEE was performed
only when TTE was suspicious for the presence of an atrial
thrombus, the study does not estimate the sensitivity of TTE in
detecting intracardiac thrombi. Finally, although no embolic
events were reported in any patient, pulmonary perfusion was
not routinely evaluated following electrical cardioversion in
patients with right atrial stasis or enlargement. It is possible
that asymptomatic, clinically insignificant microemboli to
lungs from right atrial thrombi undetected by a screening TTE
may occur with this strategy. Despite these limitations, the 
reported findings are important and hypothesis generating for
this population. Larger, prospective multicenter studies with
concurrent TTE and TEE may further help characterize the
sensitivity of TTE in detecting intracardiac thrombi and could
develop an effective strategy for managing these patients.
Conclusion
In a management strategy that employed TTE as the screen-
ing imaging modality prior to electrical cardioversion, young
patients with AFF had no thromboembolic events. This strate-
gy needs to be evaluated prospectively in a larger cohort of
young patients with AFF. 
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